Stephen G. Jenkins

Outcomes of Carbapenem-Resistant <i>Klebsiella pneumoniae</i> Infection and the Impact of Antimicrobial and Adjunctive Therapies

Gopi Patel, Shirish Huprikar, Stephanie H. Factor et al. · Infection Control and Hospital Epidemiology · 2008 · 838 citations

Life Sciences, Infectious Diseases, Antimicrobial Resistance +14

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi et al. · The Lancet · 2021 · 564 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +6

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 521 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +11

Modified Carbapenem Inactivation Method for Phenotypic Detection of Carbapenemase Production among Enterobacteriaceae

Virginia Pierce, Patricia J. Simner, David Lonsway et al. · Journal of Clinical Microbiology · 2017 · 396 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2022 · 384 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +14